Pancreatico-biliary cytology: a practical approach to diagnosis. Corina Cotoi

Similar documents
Standardized Terminology in Pancreatobiliary Cytology: The Papanicolaou Society Guidelines

CYTOLOGY OF EUS- GUIDED FNA OF THE PANCREAS AND THE UPPER GI TRACT

Case 1. Case 1: EUS Report 5/1/2017. Interesting Cases of Pancreatic Masses

Patient History. A 58 year old man presents with a 16 mm cyst in the pancreatic tail. The cyst is unilocular with a thick wall and no mural nodule.

Pancreatitis: A Potential Pitfall in Endoscopic Ultrasound Guided Pancreatic FNA

Standardization of Nomenclature

40th European Congress of Cytology Liverpool, UK, 2-5 th October 2016

Outline 11/2/2017. Pancreatic EUS-FNA general aspects. Cytomorphologic features of solid neoplasms/lesions of the pancreas

Select problems in cystic pancreatic lesions

Video Microscopy Tutorial 19

Conflicts of Interest

Pancreatic Cytopathology: A pragmatic approach. By Dr Miguel Perez-Machado MD. PhD. MRCPath Royal Free Hospital

Evaluation and Management of Cystic Lesions of the Pancreas: When to Resect, When to Follow and When to Forget

Objectives. Pancreatic Cysts. Benefits and Limitations of the Cytologic Assessment of Cystic Pancreatic Lesions and Masses

Neoplasias Quisticas del Páncreas

Biliary Tract Neoplasia: A Cyto-histologic Review. Michelle Reid, MD, MSc Professor of Pathology Director of Cytopathology Emory University Hospital

Pancreatic Cysts. Darius C. Desai, MD FACS St. Luke s University Health Network

Suspicious Cytologic Diagnostic Category in Endoscopic Ultrasound-Guided FNA of the Pancreas: Follow-Up and Outcomes

Pancreatic Cytopathology: The Solid Neoplasms

An Approach to Pancreatic Cysts. Introduction

Pancreatic Cystic Lesions 원자력병원

Advances in Pancreatic. Cytology. Martha B. Pitman, MD. Disclosure of Relevant Financial Relationships

Outline. Intraductal Papillary Mucinous Neoplasm (IPMN) Guideline Review 4/6/2017. Case Example Background Classification Histology Guidelines

Pancreatic Cystic Neoplasms: Guidelines and beyond

Matthew McCollough, M.D. April 9, 2009 University of Louisville

Team approach is essential incorporating: radiology, gastroenterology, surgery and pathology Successful performance is operator dependent

Endoscopic Ultrasound-guided FNA Cytology of the Pancreas

Appendix 4: WHO Classification of Tumours of the pancreas 17

DIAGNOSTIC CHALLENGES Pancreas FNAB. Dr. M. Weir Oct 2017

ROSE in EUS guided FNA of Pancreatic Lesions

Biliary cytolgy and pancreatic endoscopic ultrasound-guided FNA. Leena Krogerus Helsinki, FINLAND

The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms

Evaluation of AGA and Fukuoka Guidelines for EUS and surgical resection of incidental pancreatic cysts

Pancreatic Cysts. Pancreatic Cysts. Multidisciplinary and Multimodal Approach To the Pre-Operative Diagnosis of Pancreatic Cysts

ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts

Management A Guideline Based Approach to the Incidental Pancreatic Cysts. Common Cystic Pancreatic Neoplasms.

ENDOSCOPIC ULTRA SOUND GUIDED FNA OF GI TRACT AND PANCREAS

The Pancreas. Basic Anatomy. Endocrine pancreas. Exocrine pancreas. Pancreas vasculature. Islets of Langerhans. Acinar cells Ductal System

EUS-guided FNAB. Differential Diagnosis 5/1/2017. EUS-FNA of Solid and Cystic Lesions:

EUS-FNAB of GI Tract: Specimen Handling and Triage

Biliary cytolgy and pancreatic endoscopic ultrasound-guided. Helsinki, FINLAND

Solid pseudopapillary tumour of the pancreas: Report of five cases

Biliary tract tumors

INTRODUCTION TO PATHOLOGICAL TECHNIQUES. 1. Types of routine biopsy procedures 2. Special exams (IHC, FISH)

Cytology Specimen Management, Triage and Standardized Reporting of Fine Needle Aspiration Biopsies of the Pancreas

Guidelines for Pancreaticobiliary Cytology from the Papanicolaou Society of Cytopathology: A Review

State of the Art Symposium

Atypical Pancreatic Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology: A Study of Interobserver Agreement

Cystic pancreatic lesions A proposal for a network approach. Chris Briggs Consultant HPB Surgeon Peninsula HPB Unit Derriford Hospital, Plymouth

X-ray Corner. Imaging of The Pancreas. Pantongrag-Brown L

The Role of Molecular Analysis in the Diagnosis and Surveillance of Pancreatic Cystic Neoplasms

Cystic Pancreatic Lesions: Approach to Diagnosis

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds

"Atypical": Criteria and

Hepatobiliary and Pancreatic Malignancies

Cytopathology Study Day 16 April RCPath - BAC. Digital cytology: EUS FNA pancreas and head and neck

Chronic pancreatitis mimicking intraductal papillary mucinous neoplasm of the pancreas; Report of tow cases

Pancreatobiliary Frozen Section Nightmares

Update on Thyroid FNA The Bethesda System. Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center

Workshop 9. Cytopathology of Solid and Cystic Neoplasms of the Pancreas: Everything You Need To Know For Daily Practice.

5/21/2018. An Update on Pancreas Neoplasms. Arief Suriawinata, M.D. Lines of Differentiation in Pancreatic Neoplasms

Radiology Pathology Conference

Atypia in Diagnostic Cytopathology: Strategies to Reduce Overuse A CQI initiative

CHRONIC PANCREATITIS OR DUCTAL ADENOCARCINOMA? N. Volkan Adsay, \ MD

Oncocytic-Appearing Salivary Gland Tumors. Oncocytic, Cystic, Mucinous, and High Grade Salivary Gland Tumors SALIVARY GLAND FNA: PART II

Salivary Gland Cytology: A Clinical Approach to Diagnosis and Management of Atypical and Suspicious Lesions

Pancreatic malignant tumors are the fifth leading cause of cancerrelated

EUS-FNA OF PANCREATIC EXOCRINE TUMORS COMPARISON OF EXPERIENCES WITH PATHOLOGICAL DIAGNOSIS

Diagnostic performance of endoscopic ultrasound-guided fine-needle aspiration in pancreatic lesions

Thyroid follicular neoplasms in cytology. Ulrika Klopčič Institute of Oncology, Department of Cytopathology, Ljubljana, Slovenia

CT 101 :Pancreas and Spleen

EUS-guided FNAB. Differential Diagnosis 3/14/2018. EUS-FNA of Solid and Cystic Lesions: Part 1: Solid Masses

Salivary Gland Cytology

Types of IPMN. Pancreas Cysts: An Incidental Finding or Harbinger of Malignancy. Cysts: Early Neoplasia. Mucinous Cystic Lesions. EUS-guided FNA EUS

Endoscopic Ultrasonography Clinical Impact. Giancarlo Caletti. Gastroenterologia Università di Bologna. Caletti

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98

Thyroid master class. Thyroid Fine needle aspiration cytology and liquid-based techniques: Hologic and Becton Dickinson

Objectives. Salivary Gland FNA: The Milan System. Role of Salivary Gland FNA 04/26/2018

Citation American Journal of Surgery, 196(5)

Case #1 FNA of nodule in left lobe of thyroid in 67 y.o. woman

PANCREATIC CYTOPATHOLOGY: PRACTICAL POINTS TO AVOID COMMON PITFALLS

DOWNLOAD ENTIRE DOCUMENT FROM

Respiratory Tract Cytology

Case Scenario 1. Discharge Summary

Research Article The Changing Spectrum of Surgically Treated Cystic Neoplasms of the Pancreas

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.

Predictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases

Three Cases of Concomitant Intraductal Papillary Mucinous Neoplasm and Pancreatic Neuroendocrine Tumour

Intraductal Papillary Mucinous Neoplasms: We Still Have a Way to Go! Francesco M. Serafini, MD, FACS

Pancreatic neoplasms associated with significant amounts of extracellular. Fine-Needle Aspiration Cytology of Mucinous Tumors of the Pancreas CANCER

Evaluation of Suspected Pancreatic Cancer

Salivary Glands 3/7/2017

Thyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS

Medullary Thyroid Carcinoma. This case was provided by Treant Hospital, Bethesda, Hoogeveen, The Netherlands

Cytology for the Endocrinologist. Nicole Massoll M.D

Lung Cytology: Lessons Learned from Errors in Practice

Intraductal Papillary Mucinous Neoplasm of Pancreas

Unusual Pancreatic Neoplasms RTC 2/11/2011

Cystic lesions of the pancreas

EUS FNA NEUROENDOCRINE TUMORS. A. Ginès Endocopy Unit Hospital Cínic. Barcelona (Spain)

Transcription:

Pancreatico-biliary cytology: a practical approach to diagnosis Corina Cotoi

Pancreatico-biliary lesions Solid: Ductal adenocarcinoma Cholangiocarcinoma Acinar cell carcinoma Neuroendocrine tumour / carcinoma Inflammatory conditions: AIP, CP Splenunculus Lymphoma Metastatic tumours Cystic Pre-malignant: IPMN, MCN Benign: serous cystadenoma Low grade malignant potential: solid pseudopapillary neoplasm Cystic transformation of NET Lymphoepithelial cysts

Diagnosis of pancreatic lesions Clinical symptoms:?painless jaundice Tumour markers (eg CA19.9) Imaging: US, CT, MRI, EUS, ERCP, MRCP, functional imaging Cytology (brushings, FNAs) Cystic lesions Fluid CEA >192 ug/ml (can be falsely elevated: lymphoepithelial cysts, mesothelial inclusion cysts) Amylase: very high in pseudocysts (falsely elevated in other cystic lesions) Molecular analysis: K-Ras (IPMN, MCN), GNAS (IPMN) Biopsies Diagnostic laparoscopy

Solid lesions Mass on imaging Stricture of CBD, ductal dilatation, double duct sign Raised tumour markers Biliary brushings or FNA for cytology Discussion at the MDM

Cystic lesions MRI characterisation of the cyst? tumour markers EUS?relationship to the main pancreatic duct Worrisome features: eg mural nodule, thick wall Characterisation of fluid (?mucinous) Biochemistry: fluid CEA, amylase FNA for cytology Discussion at the MDM

Biliary brushings and FNAs Brushings: For investigation of biliary strictures During ERCP FNA: cystic lesions +/- solid lesions (TruCut biopsies) During EUS

Approach to diagnosis (RCPath guidelines) immediate on-site assessment of adequacy direct air-dried smears are preferable collection in liquid medium (saline or other liquid media for LBC or cell block preparation) cytospins are generally suitable for cyst fluid Romanowsky staining, Papanicolaou staining, H&E (no benefit over PAP) Immunohistochemistry (on cell blocks, LBC samples, cytospins) No consensus on standardised reporting (?C1-C5)

Pancreatic FNA - normal

Biliary brushing - normal

GI contaminant Gastric: Mucin Stripped nuclei Nuclear grooves Cup shaped mucin Duodenal: In general large sheets Brush border Goblet cells Thin mucin

Approach to diagnosis Clinical/radiological features are important ERCP/EUS report accompanies the cytology request form Fluid characterisation and CEA/amylase fluid analysis CytoSpin (FNA cyst) and recently ThinPrep (biliary brushings) PAP staining very useful in characterising the cellular nuclear features KRAS/GNAS mutation analysis for mucinous cystic lesions not routine practice

Approach to diagnosis Adequacy: the context is important, presence of epithelial cells is not always a sign of non-diagnostic sample Background o Thick mucin o Inflammation o Necrosis Epithelial cells:?double population, atypical single cells o Cytoplasm: mucinous, granular o Nuclei: anisokaryosis (more that 1:3-1:4), nuclear crowding, irregular nuclear contours, prominent nucleoli, abnormal chromatin pattern, increased nuclear:cytoplasmic ratio

Standardised reporting Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology Guidelines Martha B. Pitman, Barbara A. Centeno, Syed Z. Ali, Muriel Genevay, Ed Stelow, MD,Mari Mino-Kenudson, Carlos Fernandez-del Castillo, C. Max Schmidt, William R. Brugge, and Lester J. Layfield PROPOSED PANCREATOBILIARY TERMINOLOGY CLASSIFICATION SCHEME I Non-diagnostic II Negative (for malignancy) III Atypical IV Neoplastic: Benign or Other V Suspicious (for malignancy) VI Positive/malignant

Standardised reporting CATEGORY I Non-diagnostic no diagnostic or useful information about the solid or cystic lesion for example, an acellular aspirate of a cyst without evidence of a mucinous etiology (such as thick colloid-like mucus, elevated CEA or KRAS/GNAS mutation - see Category IV). Any cellular atypia precludes a non-diagnostic report

Standardised reporting CATEGORY II Negative (for malignancy) Descriptive, without a diagnosis of a specific condition such as chronic pancreatitis or pseudocyst not synonymous with a benign lesion adequate cellular and/or extracellular tissue to evaluate or define a lesion that is identified on imaging. should give a specific diagnosis when practical including: Benign pancreatobiliary tissue in the setting of vague fullness and no discrete mass Acute pancreatitis Chronic pancreatitis Autoimmune pancreatitis Pseudocyst Lymphoepithelial cyst Splenule/accessory spleen

Standardised reporting CATEGORY III: ATYPICAL reactive changes low cellularity premalignant changes (dysplasia, PanIN) observer caution in diagnosis. raises the possibility of a neoplasm may be suggestive of a low-grade neoplasm, but the cytological findings are insufficient to be suspicious for a high-grade malignancy / tissue is insufficient for confirmation of a specific diagnosis cytoplasmic, nuclear, or architectural features that are not consistent with normal or reactive cellular changes of the pancreas or bile ducts and are insufficient to classify them as a neoplasm or suspicious for a high-grade malignancy insufficient to explain the lesion seen on imaging Follow-up evaluation is warranted.

Standardised reporting CATEGORY IV: NEOPLASTIC Category IVA: Neoplastic: Benign cytological specimen sufficiently cellular and representative with or without the context of clinical, imaging and ancillary studies diagnostic of a benign neoplasm

Standardised reporting CATEGORY IV: NEOPLASTIC Category IVB: Neoplastic: Other pre-invasive, premalignant neoplasms (IPMN and MCN with low, intermediate or high grade dysplasia) low-grade malignant behaviour pancreatic neuroendocrine tumor (pnet) solid-pseudopapillary neoplasm (SPN) that warrant distinction from aggressive, high-grade malignancies

Standardised reporting CATEGORY V: SUSPICIOUS (FOR MALIGNANCY)! Suspicious for is NOT diagnostic of Correlation with the clinical and radiological findings insufficient number of the typical features of a specific malignant neoplasm qualitatively and/or quantitatively insufficient for a conclusive diagnosis of malignancy tissue is not present for ancillary studies to define a specific neoplasm malignancy is considered more probable than not

Standardised reporting CATEGORY VI: POSITIVE OR MALIGNANT ductal adenocarcinoma and other high-grade malignancies unequivocally display malignant cytologic characteristics includes PDAC and its variants, cholangiocarcinoma, acinar cell carcinoma, high-grade neuroendocrine carcinoma (small cell and large cell), pancreatoblastoma, lymphomas, sarcomas and metastases to the pancreas

Case 1 - cytology 80 y.o. female, Hilar stricture? malignancy.

Case 1 - cytology

Case 1 - diagnosis Cellular sample, satisfactory for evaluation. Negative for malignancy (reporting category II*).

Case 2 - cytology 53 y.o male, EUS: cystic structure with features of pseudocyst fluid amylase of 27000IU/L

Case 2 - cytology

Case 2 - diagnosis Satisfactory for evaluation. Negative for malignancy (reporting category II*). See comment. COMMENT: The findings are in keeping with the clinical impression of a pseudocyts (fluid amylase of 27000IU/L supports this diagnosis).

Case 3 - cytology 56 y.o. female Known PSC with biliary stricture of the right hepatic duct. ERCP and biliary brushings.

Case 3 - cytology

Case 3 - diagnosis Cellular sample, satisfactory for cytological evaluation. Atypical (reporting category III*). See comment. COMMENT: There is mild epithelial atypia, interpreted as reactive rather than neoplastic in the context of PSC Please note that chronic cholangiopaties are inflammatory conditions that lead to severe reactive atypia, sometimes difficult to differentiate from neoplasia. FISH, NGS: used in some centres, but not routine practice

Case 4 - cytology 75 y.o male Biliary obstruction and pancreatic mass. ERCP and brushings.

Case 4 - cytology

Case 4 - histology Mixed ductal neuroendocrine carcinoma

Case 4 - histology Mixed ductal neuroendocrine carcinoma

Case 5 - cytology Pancreatic cyst FNA Multi-cystic tumour in body of pancreas. Fluid amylase 1149 UI/l. CEA <2. EUS DG Vascular tumour - large. Suitable for resection.

Case 5 - diagnosis Cellular sample, satisfactory for cytological evaluation. Neoplastic: Benign (reporting category IVA*). See comment. COMMENT: The findings are in keeping with a serous cystadenoma. Low fluid CEA, lack of thick mucus and the bland epithelial cells, in places with clear cytoplasm support the diagnosis. Cytology slide circulation: 60% SCA (IVA), 40% SCA/NET (IVA-IVB)

Case 5 - histology Distal pancreatectomy: Pancreatic serous cystic neoplasm (microcystic serous cystadenoma).

Case 6 - cytology Pancreatic cyst, FNA, 16 y.o. female Endoscopic ultrasounds. 2.6 cm pancreatic cyst?debris within it?solid component. Single pass, sent for histology and cytology (transgastric approach). Fluid CEA < 2 ug/l, amylase 213 UI/l

Case 6 - cytology

Case 6 - cytology CD10 Beta-catenin Beta-catenin Synaptophysin

Case 6 - diagnosis Cellular sample, satisfactory for cytological evaluation. Neoplastic: Other (reporting category IVB*). See comment. COMMENT: The cytological and immunohistochemical findings are in keeping with a solid-pseudopapillary neoplasm.

Case 6 - histology

Case 6 Solid-pseudopapillary tumour Alpha 1 antitrypsin positive Differential Diagnosis: Neuroendocrine tumour Acinar cell carcinoma Serous cystadenoma Alpha 1 antichymotrypsin Neuron specfic enolase Vimentin Progesterone receptor Beta-catenin CD10 CD56 Trypsin Chymotrypsin CD117 Cytokeratins Synaptophysin CD34 Estrogen receptor Chromogranin positive positive positive positive positive positive positive negative negative positive variable ~ half of cases negative negative negative

Case 7 - cytology 50 y.o. male Pancreatic FNAB Uncinate process tumour, well demarcated.

Case 7 - cytology Synaptophysin Chromogranin

Case 7 - diagnosis Cellular sample, satisfactory for cytological evaluation. Neoplastic: Other (reporting category IVB*). See comment. COMMENT: The cytological and immunohistochemical findings are in keeping with a well differentiated neuroendcrine tumour.

Case 7 - histology Synaptophysin Ki67 Chromogranin

Case 8 - cytology Pancreatic cyst fluid FNA Query IPMN and dysplasia. CEA 5331 ug/l amylase 1879 UI/l, mucinous fluid aspirated

Case 8 - cytology

Case 8 - diagnosis Paucicellular sample, limiting cytological evaluation. Neoplastic: Other (reporting category IVB*). See comment. COMMENT: Although no thick mucus is seen, the high CEA and the aspirated mucinous fluid support a diagnosis of a mucinous cystic lesion. No high grade atypia is seen, but the sample is limited. Cytology slide circulation: 100% agreement in diagnosis

Case 8 - histology IPMN with low and intermediate grade dysplasia

Case 8 - histology Cytological criteria of high-grade epithelial atypia in the cyst fluid of pancreatic intraductal papillary mucinous neoplasms. Pitman MB, Centeno BA, Daglilar ES, Brugge WR, Mino-Kenudson M. Cancer Cytopathology, 2014 Agreement between cytopathologists: Significantly different between the LGD and HGD groups included: 1) cell size < a 12-μm duodenal enterocyte for HGD and equal size for LGD 2) increased nuclear-to-cytoplasmic (N/C) ratio; 3) marked nuclear membrane abnormalities; 4) abnormal chromatin pattern (hypo or hyperchromasia) 5) background necrosis

Case 9 - cytology 59 y.o. male Imaging revealed dilated intraphepatic ducts and hilar mass infiltrating the liver. Biliary brushing History of colon cancer

Case 9 - cytology

Case 9 - histology

Case 9 - histology CK7 CK20 Intestinal-type adenocarcinoma in keeping with colo-rectal metastasis CDX2

Case 10 - cytology 78 y.o, male Jaundice.?cholangiocarcinoma. ERCP: Mid CBD stricture. biliary brushings

Case 10 - cytology

Case 10 - diagnosis Cellular sample, satisfactory for cytological evaluation. Positive/malignant (reporting category VI*).

Case 10 - histology Distal cholangiocarcinoma

Case 10 - histology

THANK YOU corina.cotoi@nhs.net I would like to thank: Dr Maesha Deheragoda - for clinical cover Alessandra Pacheco - for preparing the cases for today and doing an excellent job in processing and staining our cytology samples